Introduction
============

Osteonecrosis of the femoral head (ONFH) is a crippling disease which was caused by multiple etiologies ([@ref-22]). It has an incidence estimated at 150,000 to 200,000 new cases in China ([@ref-24]) and 20,000 new cases in the United States per year ([@ref-23]). However, the molecular etiology and pathogenesis of ONFH still remain elusive, which impedes the development of effective precautions in its earlier stages and leaves a large number of ONFH patients to total hip replacement. Potential causes of ONFH include trauma, steroids, alcoholism, irradiation and so on ([@ref-14]). These risk factors could lead to ischemic changes and eventually result in femoral head collapse and secondary arthritis ([@ref-4]). In the early stages of ONFH, the injured blood supply leads to local osteonecrosis and osteoclast-mediated bone resorption ([@ref-10]). Then the osteoblast-mediated reparative reaction initiated ([@ref-3]; [@ref-23]). However, the imbalance between bone reformation and resorption lead to structural damage and collapse of the femoral head ([@ref-16]). Cartilaginous tissues of the collapsed femoral head are eventually degenerated and softened due to the reduction of nutritional support from subchondral bone ([@ref-18]; [@ref-21]). The degenerated articular cartilage could increase the instability of hip which accelerates the development process of ONFH ([@ref-12]).

With the developing of microarray and sequencing technology, many attempts have been made to reveal the expression profile of RNAs of bone and bone marrow in ischemic femoral head ([@ref-5]; [@ref-15]; [@ref-28]). In the past few years, some studies focused on the gene expression profiling of hip articular cartilage from ONFH cases in order to reveal the potential mechanisms of damage to articular cartilage. Liu et al. conducted a genome-wide gene expression profiling of hip articular cartilage with ONFH ([GSE74089](GSE74089)) and identified 27 differently expressed genes in ONFH articular cartilage ([@ref-16]; [@ref-29]). However, to date and the best of our knowledge, there is no study has been done to analyze the differential expression of critical chondrogenesis-related and arthritis-related in human ONFH cartilage with different stages.

In this study, based on the dataset [GSE74089](GSE74089) from the Gene Expression Omnibus (GEO) database of the National Center of Biotechnology Information (NCBI, <http://www.ncbi.nlm.nih.gov/geo/>), we analyzed the differentially expressed genes (DEGs) via bioinformatics methods and selected six chondrogenesis-related DEGs and four arthritis-related genes. Then these ten DEGs were validated by 8 human hip articular cartilage with femoral neck fracture (FNF) and 26 human hip articular cartilage with different stages ONFH. Therefore, the aim of our study is to explore the expression changes of critical chondrogenesis-related DEGs and arthritis-related genes in human ONFH cartilage with different stages, which may contribute to a better understanding of the molecular mechanisms of ONFH pathogenesis.

Materials and Methods
=====================

Microarray data and DEGs
------------------------

The date of gene expression microarray [GSE74089](GSE74089) ([GPL13497](GPL13497), Agilent-026652 Whole Human Genome Microarray 4x44K v2; Agilent Technologies Inc., California, USA) was downloaded from GEO datasets. The tested specimens of this gene expression profile contained four hip cartilage samples of ONFH and 4 hip cartilage samples of healthy control. The GEO2R (<https://www.ncbi.nlm.nih.gov/geo/geo2r/>), an interactive online tool, was applied to analyze the DEGs of ONFH cartilage samples. The group names (test group and control group) were entered after 'Define groups' was clicked. ONFH cartilage samples were assigned to test group and FHF cartilage samples were assigned to control group. Then the adjustment was applied to the P-values (Benjamini & Hochberg). The adjusted *P* \< 0.05 and \|LogFC\| ≥ 2 were set as the cut off criterions. Then a volcano map was generated according to these criterions.

GO and KEGG analysis
--------------------

Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis were performed via using The Database for Annotation, Visualization and Integrated Discovery (DAVID, <https://david.ncifcrf.gov/)> tool ([@ref-8]), an online bioinformatics tool which provides a functional interpretation of large lists of genes or proteins. The up-regulated DEGs and down-regulated DEGs were analyzed separately in order to get a better understanding of potential functions of DEGs in ONFH cartilage.

ONFH and FHF articular cartilage specimens
------------------------------------------

A total of 8 hip articular cartilage specimens were collected from FHF patients as control subjects. The ONFH hip articular cartilage specimens were collected from 26 ONFH patients who were undergoing total hip replacement at the Second Hospital of Jilin University. According to the Ficat classification ([@ref-26]), these 26 ONFH hip articular cartilage specimens were divided into three groups (6 cases Ficat stage II, 10 cases Ficat stage III and 10 cases Ficat stage IV) as shown in [Table 1](#table-1){ref-type="table"}. Patients concurrent with severe chronic diseases, such as congenital diseases, cardiovascular diseases, diabetes mellitus, renal dysfunction, HIV infection, and cancer, were excluded. All cartilage specimens were sliced to 3 mm depth by a fresh scalpel blade during the operation ([Fig. 1](#fig-1){ref-type="fig"}). This study was approved by the ethics committee of the Second Clinical College of Jilin University (NO. 2018-082) and all participants have been provided informed consent for their taking part in the study.
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###### Characteristics of study subjects.
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              Number of subjects   Age (years, mean  ± SD)   Sex   
  ----------- -------------------- ------------------------- ----- ---
  Control     8                    74.13 ± 5.49              2     6
  Ficat II    6                    58.5 ± 10.61              5     1
  Ficat III   10                   59.14 ± 11.94             9     1
  Ficat IV    10                   58.75 ± 3.30              7     3

![Images of femoral heads and position of specimens.\
(A) from patient with FHF; (B) from patient with ONFH Ficat stage II; (C) from patient with ONFH Ficat stage III; (D) from patient with ONFH Ficat stage IV.](peerj-07-6306-g001){#fig-1}

RNA preparation
---------------

Total RNAs of all cartilage specimens were extracted using TRIzol (Invitrogen) following the manufacturer's introductions. Then RNA concentration was measured by Agilent ND-1000. The cDNAs were synthesized by reverse transcription from total RNA using oligo(dT) primer method (PrimeScriptTMRT Reagent Kit; TaKaRa, Kusatsu, Japan).

qRT-PCR validation of chondrogenesis-related and arthritis-related genes
------------------------------------------------------------------------

A total of 6 chondrogenesis-related genes were selected for qRT-PCR validation, including matrix metallopeptidase 13 (MMP13), asporin (ASPN), collagen type I alpha 1 chain (COL1A1), osteoglycin (OGN), collagen type II alpha 1 chain (COL2A1) and bone morphogenetic protein 2 (BMP2) ([@ref-2]; [@ref-6]; [@ref-20]; [@ref-27]; [@ref-31]), based on results from previous studies and gene function. 4 arthritis-related genes, including interleukin 1 beta (IL1*β*), interleukin 6 (IL6), tumor necrosis factor alpha (TNF*α*) and prostaglandin-endoperoxide synthase 2 (PTGS2) ([@ref-3]), were also selected ([Table 2](#table-2){ref-type="table"}). Quantitative real-time PCR was performed using SYBR Green qPCR Master Mix (Thermo Fisher Scientific). The expression of each mRNA was normalized relative to the endogenous control of human glyceraldehyde-3-phosphate dehydrogenase (GAPDH). The relative expression was calculated using the 2^−ΔΔCt^ method. All the primers were shown in [Table 3](#table-3){ref-type="table"}.
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###### Selected chondrogenesis-related and arthritis-related genes.
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  Official symbols   Gene names                              Functions                      Fold Change (logFC)
  ------------------ --------------------------------------- ------------------------------ ---------------------
  MMP13              matrix metallopeptidase 13              Extracellular matrix           6.54
  COL1A1             collagen type I alpha 1 chain           Extracellular matrix           5.77
  ASPN               asporin                                 Extracellular matrix           4.33
  OGN                osteoglycin                             Extracellular matrix           3.62
  COL2A1             collagen type II alpha 1 chain          Extracellular matrix           2.35
  BMP2               bone morphogenetic protein 2            Cartilage development          2.64
  IL1*β*             interleukin 1 beta                      Inflammation                   −0.13
  IL6                interleukin 6                           Inflammation                   −1.01
  TNF*α*             tumor necrosis factor alpha             Inflammation                   −1.51
  PTGS2              prostaglandin-endoperoxide synthase 2   Inflammation and mitogenesis   3.64
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###### The primers of mRNAs.
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  Gene     **Primer sequences**                 
  -------- ------------------------------------ -----------------------------------
  MMP13    F: 5′-AGCTGGACTCATTGTCGGGC-3′        R: 5′-AGGTAGCGCTCTGCAAACTGG-3′
  COL1A1   F: 5′-GGGATTCCCTGGACCTAAAG-3′        R: 5′-GGAACACCTCGCTCTCCAG-3′
  ASPN     F: 5′-TTGAAGGGGTGACGGTGTTC-3′        R: 5′-AGTGAAGCTCCAATAAAGTTGGT-3′
  OGN      F: 5′-GCTGAAATGGAGACTGTGCACTCTA-3′   R: 5′-GTTAGAAGTATGACCCTATGGGTA-3′
  COL2A1   F: 5′-GTGTCAGGGCCAGGATGT-3′          R: 5′-TCCCAGTGTCACAGACACAGAT-3′
  BMP2     F: 5′-TGAGGATTAGCAGGTCTTTG-3′        R: 5′-CACAACCATGTCCTGATAAT-3′
  IL1*β*   F: 5′-TGAGCTCGCCAGTGAAATGA-3′        R: 5′-AACACGCAGGACAGGTACAG-3′
  IL6      F: 5′-CTCAATATTAGAGTCTCAACCCCCA-3′   R: 5′-GAGAAGGCAACTGGACCGAA-3′
  TNF*α*   F: 5′-CTGGGCAGGTCTACTTTGGG-3′        R: 5′-CTGGAGGCCCCAGTTTGAAT-3′
  PTGS2    F: 5′-GTTCCACCCGCAGTACAGAA-3′        R: 5′-AGGGCTTCAGCATAAAGCGT-3′
  GAPDH    F: 5′-CGGACCAATACGACCAAATCCG-3′      R: 5′-AGCCACATCGCTCAGACACC-3′

The protein-protein interaction (PPI) networks
----------------------------------------------

GeneMANIA (<http://www.genemania.org/>) is a web-based database and a tool for the prediction of gene functions on the basis of multiple networks derived from different genomic or proteomic data sources ([@ref-9]). It is fast enough to predict gene functions with great accuracy by using GeneMANIA because hundreds of datasets from I2D, BioGRID, GEO and Pathway Commons, as well as organism-specific functional genomics data sets, have been collected in this software. A protein-protein interaction (PPI) network of above chondrogenesis-related and arthritis-related genes was generated using GeneMANIA.

Statistical analysis
--------------------

The adjusted *P* \< 0.05 and \|LogFC\| ≥ 2 were set as the cut off criterions for DEGs. The bar graphs of GO enrichment were constructed by Microsoft Excel software and *P* \< 0.05 indicated that the difference was statistically significant. The volcano map and frequency distribution maps of DEGs were conducted using GraphPad Prism 7.0 (GraphPad Software Inc., La Jolla, CA, USA).

Results
=======

Differentially expressed genes
------------------------------

The volcano plots showed the variation of gene expression between ONFH and FHF cartilage samples ([Fig. 2](#fig-2){ref-type="fig"}). Based on the thresholds of adjusted *P* \< 0.05 and \|LogFC\| ≥ 2, a total of 2174 DEGs were obtained in the ONFH cartilage specimens compared to the control group, including 1482 up-regulated and 692 down-regulated ones.

![The volcano plot was constructed using fold-change (LogFC) values and adjusted *P*-values.\
The vertical green lines correspond to 2.0-LogFC up and down and the horizontal green line represents an adjusted *P*-value of 0.05. The red point represents the differentially expressed genes with statistical significance.](peerj-07-6306-g002){#fig-2}

GO and KEGG enrichment of DEGs
------------------------------

For a better understanding of the DEGs, GO function and KEGG pathway enrichment analysis were applied using DAVID. The GO analysis results indicated that biological processes (BP) of up-regulated DEGs were particularly enriched in extracellular matrix organization, collagen catabolic process collagen fibril organization and so on. The BP of down-regulated DEGs were mainly enriched in antigen processing and presentation of peptide or polysaccharide antigen via MHC class II, interferon-gamma-mediated signaling pathway, antigen processing, and presentation and so on. For cell component (CC), the upregulated DEGs were enriched in extracellular matrix, proteinaceous extracellular matrix, extracellular space and so on, while the down-regulated DEGs were enriched in MHC class II protein complex, integral component of lumenal side of endoplasmic reticulum membrane, ER to Golgi transport vesicle membrane and so on. The molecular function (MF) analysis showed that the up-regulated DEGs were significantly enriched in the protein binding, collagen binding, and extracellular matrix structural constituent, while down-regulated DEGs enriched in MHC class II receptor activity, peptide antigen binding and serine-type endopeptidase activity ([Fig. 3](#fig-3){ref-type="fig"}).

![The most 10 significant Gene Ontology (GO) enrichment items and the DEGs count.\
The biological processes (BP) of (A) up- and (B) down- regulated DEGs, respectively; The cell component (CC) of (C) up- and (D) down-regulated DEGs, respectively; The molecular function (MF) of (E) up- and (F) down-regulated DEGs, respectively. The left *Y*-axes was for *P*-value and the right *Y*-axes was for gene counts.](peerj-07-6306-g003){#fig-3}

KEGG pathway enrichment analysis was also applied by DAVID. Based on the thresholds of *P* \< 0.05, the pathway enrichment analysis indicated that the up-regulated DEGs were significantly involved in 18 pathways and the down-regulated DEGs were significantly involved in 23 pathways (*p* \< 0.05, FDR-corrected). The five most significant pathways of up-regulated and down-regulated DEGs were listed in [Table 4](#table-4){ref-type="table"}.
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###### KEGG pathway analysis of differently expressed genes.
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  Pathway terms                      *P*-value   Counts
  ---------------------------------- ----------- --------
  Up-regulated DEGs                              
  ECM-receptor interaction           9.86E−09    18
  Focal adhesion                     2.10E−08    27
  PI3K-Akt signaling pathway         1.78E−05    30
  Platelet activation                6.68E−05    16
  Protein digestion and absorption   3.13E−04    12
  Down-regulated DEGs                            
  Staphylococcus aureus infection    8.10E−20    17
  Graft-versus-host disease          8.05E−13    11
  Allograft rejection                2.93E−12    11
  Type I diabetes mellitus           1.19E−11    11
  Asthma                             1.34E−11    10

The expression levels of chondrogenesis-related and arthritis-related genes in cartilage with different Ficat stages
--------------------------------------------------------------------------------------------------------------------

To further explore the different expression levels of chondrogenesis-related genes and arthritis-related genes in cartilage with different Ficat stages, the qRT-PCR analysis was used to detect the expression levels of six chondrogenesis-related genes (MMP13, ASPN, COL1A1, OGN, COL2A1, BMP2) and four arthritis-related genes (IL1*β*, IL6, TNF*α*, PTGS2) in different Ficat stages of cartilage specimens. The results showed a significant stepwise up-expression of chondrogenesis-related genes and arthritis-related gene PTGS2 along with the progression of ONFH. Other arthritis-related genes IL1*β*, IL6 and TNF*α* were not found differentially expressed in [GSE74089](GSE74089), but they were up expressed in the Ficat IV stage ([Figs. 4](#fig-4){ref-type="fig"} and [5](#fig-5){ref-type="fig"}).

![The gene expression levels of chondrogenesis-related genes in cartilage specimens with different Ficat stages.\
(A) MMP13, (B) ASPN, (C) COL1A1, (D) OGN, (E) COL2A1, (F) BMP2. (*n* = 3; \* *p* \< 0.05, \*\* *p* \< 0.01, \*\*\* *p* \< 0.001)](peerj-07-6306-g004){#fig-4}

![The gene expression levels of arthritis-related genes in cartilage specimens with different Ficat stages.\
(A) IL1 *β*, (B) IL6 , (C) TNF *α* , D) PTGS2 . (*n* = 3; \* *p* \< 0.05, \*\* *p* \< 0.01, \*\*\* *p* \< 0.001).](peerj-07-6306-g005){#fig-5}

PPI network of chondrogenesis-related and arthritis-related genes
-----------------------------------------------------------------

A PPI network of six chondrogenesis-related and four arthritis-related genes was conducted, based on the information in the GeneMANIA protein query from public databases. Genes related to chondrogenesis-related genes were mainly enriched in cartilage and ECM formation. Genes related to four arthritis-related genes not only enriched in inflammation, but also enriched in growth factors and cartilage formation ([Fig. 6](#fig-6){ref-type="fig"}).

![The protein-protein interaction (PPI) network of chondrogenesis-related and arthritis-related genes.\
Their relationships were presented by lines with different colors. The percentage of co-expression, co-localization, shared protein domains, physical interactions and predicted were 76.19%, 12.63%, 5.13%, 4.17%, 1.88%, respectively.](peerj-07-6306-g006){#fig-6}

Discussion
==========

The degeneration of hip articular cartilage with ONFH has already been characterized by previous studies ([@ref-19]; [@ref-25]). Histologic changes in articular cartilage, including loss of cartilage cells, surface fibrillation, and subchondral bone thickening, may result in differential gene expression in articular cartilage ([@ref-13]). [@ref-16] conducted genome-wide gene expression profiling of hip articular cartilage in four patients with ONFH (Ficat III grade) and four controls and identified a set of differentially expressed genes in ONFH articular cartilage. We analyzed the gene expression microarray [GSE74089](GSE74089) and identified 1482 up-regulated and 692 down-regulated DEGs in ONFH cartilage based on the thresholds of adjusted *P* \< 0.05 and \|LogFC\| ≥ 2. Liu et al. identified 27 differently expressed genes in ONFH articular cartilage in their study. Based on gene function and results from previous study, nine cartilage development and damage related DEGs were selected for qRT-PCR validation in their study, including COL1A1, ANGPTL4, CRTAC1, ASPN, COL3A1, VKORC1, OGN, SPP1 and P4HA2 ([@ref-16]). Our results were different to their study as we used different analysis method and thresholds.

For a further understanding of DEGs function, GO and KEGG enrichment analysis was performed via DAVID. The GO and KEGG enrichment items of up-regulated DEGs mainly enriched in extracellular matrix, angiogenesis, osteoblast differentiation, and cell adhesion. However, items of down-regulated mainly enriched in antigen processing and presentation, MHC class II protein complex and peptide antigen binding. These items have been reported to play important role in the pathogenesis of cartilage degeneration in ONFH ([@ref-1]; [@ref-7]; [@ref-11]; [@ref-17]; [@ref-30]). As these results showed, the expression of cartilage and ECM-related gene were up-regulated and induced the process of cartilage rehabilitation in degenerated cartilage, which may result from a number of stimuli factors such as hypoxia and ischemia in cartilage. Simultaneously, the down-regulation of antigen processing associated genes indicated the weakened immune responses in degenerated cartilage, which may be an activation of cartilage protection. The differential expression of these genes may be due to the response to hypoxia and ischemia of cartilage, but it failed to change the fact that the cartilage degenerated progressively.

The DEGs seem to be important not only for their roles in disease progression but also for their potential as molecular markers. In order to further explore the molecular changes along with the progression of ONFH, we selected six chondrogenesis-related and four arthritis-related genes and detected their expression levels in ONFH articular cartilage with different Ficat stages. The results showed a significant stepwise up-expression of chondrogenesis-related genes along with the progression of ONFH ([Fig. 4](#fig-4){ref-type="fig"}), which indicated that the stimulation of cartilage rehabilitation in degenerated cartilage enhanced with the progress of the disease. To explore the arthritis progress in ONFH, four arthritis-related genes were detected. Although IL1*β*, IL6, and TNF*α* were not found differentially expressed in the Ficat IV stage, they were up expressed in the Ficat IV stage in our verification test, which indicated that the arthritis-related molecular changes were not significant in the progression of ONFH before the Ficat III stage. But there is indeed significant change in the Ficat IV stage. However, PTGS2 was significantly stepwise up-expressed along with the progression of ONFH which makes it to be a sensitive biomarker in the arthritis process of ONFH. In order to explore the interaction and relationship between chondrogenesis-related genes and arthritis-related genes, we conducted a PPI network and the result showed their relationships mainly enriched in co-expression (76.19%) and co-location (12.63%). The PPI result indicated that there are many interconnections among these genes which may play critical roles in the progression of ONFH.

It should be noted that there are still some limitations in our study. Large sample size was still needed to confirm our findings. In addition, further studies are needed to explore the exact regulation mechanism between chondrogenesis-related genes and arthritis-related genes in the progression of ONFH.

Conclusion
==========

We analyzed a gene expression profile of ONFH and validated the expression changes of selected six chondrogenesis-related and four arthritis-related genes in hip articular cartilage specimens with different ONFH Ficat stages. These findings are expected to get a further insight into the molecular mechanisms of ONFH progression.
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